Not in the current Orange Book— This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
SUGAMMADEX SODIUM | A213915 | MYLAN
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Merck Sharp & Dohme B.V. et al v. Mylan Pharmaceuticals Inc. et al 2 patentsANDA 213915sugammadex | N.D. W. Va. | 2020-04-02 | Terminated 2022-08-08 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.